Mesa Laboratories Inc (MLAB)

Working capital turnover

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Revenue (ttm) US$ in thousands 240,978 237,747 228,380 223,712 216,187 212,874 213,688 219,272 219,080 222,368 222,777 199,868 184,335 163,420 142,896 138,916 133,937 130,181 127,664 121,340
Total current assets US$ in thousands — 110,845 107,978 106,690 109,352 118,355 117,662 114,808 118,975 114,185 116,260 128,127 124,318 120,995 319,404 315,311 303,009 295,275 280,125 269,756
Total current liabilities US$ in thousands — 155,878 153,230 54,865 44,312 44,183 39,816 39,126 43,359 41,617 41,506 44,127 48,055 46,775 28,690 33,448 32,583 27,750 19,533 20,475
Working capital turnover — — — 4.32 3.32 2.87 2.75 2.90 2.90 3.06 2.98 2.38 2.42 2.20 0.49 0.49 0.50 0.49 0.49 0.49

March 31, 2025 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $240,978K ÷ ($—K – $—K)
= —

The working capital turnover ratio of Mesa Laboratories Inc has shown fluctuating trends over the past few years. The ratio remained relatively stable around 0.49 in the period from June 2020 to March 2022. However, there was a significant increase in the ratio from December 2022 to June 2024, reaching a peak of 4.32.

This increase indicates that Mesa Laboratories Inc has been able to efficiently utilize its working capital to generate sales revenue during this period. A higher working capital turnover ratio indicates that the company is effectively managing its working capital to support its operations and generate sales.

The ratio dropping to "\u2014" in the latter part of 2024 and beyond suggests that there may be missing or unavailable data points during those periods, making it difficult to assess the trend accurately.

Overall, the increasing trend in the working capital turnover ratio from December 2022 to June 2024 reflects positively on Mesa Laboratories Inc's ability to effectively manage its working capital and generate sales. It is important for the company to continue monitoring this ratio to ensure efficient utilization of its working capital in the future.